Using statins to improve health outcomes in patients with compensated cirrhosis
Statin Therapy for patients with compensated Cirrhosis
This study is looking at whether taking statin medications can help people with compensated cirrhosis, a serious liver condition, by reducing their risk of serious health problems, and we're inviting patients from the University of Michigan's Hepatology practice to join us in this important research.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10909074 on NIH RePORTER |
What this research studies
This research investigates the potential benefits of statin therapy for patients with compensated cirrhosis, a serious liver condition. The study aims to recruit a large group of patients from the University of Michigan's Hepatology practice to gather data on their health outcomes over time. By measuring various clinical indicators and incorporating patient-reported outcomes, the research seeks to determine if statins can help reduce the risk of severe complications associated with cirrhosis. The approach includes a multicenter consortium to enhance the diversity and size of the patient cohort.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with compensated cirrhosis who are being monitored for their liver health.
Not a fit: Patients with decompensated cirrhosis or those who are not eligible for statin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that improve the quality of life and health outcomes for patients with compensated cirrhosis.
How similar studies have performed: Previous epidemiological studies have suggested that statins may reduce the risk of complications in cirrhosis, but this research aims to provide the first prospective data on their effectiveness.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Tapper, Elliot — University of Michigan at Ann Arbor
- Study coordinator: Tapper, Elliot
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.